M. Jordan
Molecular Biology · with Dumontet · 2004–2010
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 7 citations into it
Whom M. Jordan trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Jordan overall
- Beth A. Weaver
- Debashish Chowdhury
- Charles Dumontet
- S. Lapenna
- J. Gershenzon
- M. Greenwell
- D. Longley
- S. Lens
- Fuliang Xie
Papers from M. Jordan's perspective
Ordered by how strongly the researchers M. Jordan trusts endorse each paper. Same corpus, a different order for every researcher.
- Structural insights into microtubule function. (Annual Review of Biochemistry)
- Chemotherapy-induced peripheral neuropathy. (Oncology Nursing Forum)
- Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. (Cancer Research)
- Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the… (Journal of Clinical Oncology)
- Microtubules as a target for anticancer drugs (Nature Reviews. Cancer)
- Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies (Clinical Cancer Research)
- Disrupting tumour blood vessels (Nature Reviews. Cancer)
- Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. (Journal of Clinical Oncology)
- Refined structure of alpha beta-tubulin at 3.5 A resolution. (Journal of Molecular Biology)
- Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy (Nature)
Their papers
- Microtubule-binding agents: a dynamic field of cancer therapeutics (2010) — 1,617 citations
- Microtubules as a target for anticancer drugs (2004) — 4,395 citations